Revvity EBITDA Margin 2010-2023 | RVTY
Revvity EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2023-12-31 | $2.75B | $0.74B | 26.86% |
2023-09-30 | $2.80B | $0.80B | 28.54% |
2023-06-30 | $2.84B | $0.85B | 29.89% |
2023-03-31 | $3.02B | $1.02B | 33.70% |
2022-12-31 | $3.31B | $1.22B | 36.90% |
2022-09-30 | $3.00B | $1.38B | 45.92% |
2022-06-30 | $3.15B | $1.41B | 44.67% |
2022-03-31 | $3.48B | $1.46B | 41.87% |
2021-12-31 | $3.83B | $1.61B | 42.07% |
2021-09-30 | $3.63B | $1.63B | 44.88% |
2021-06-30 | $3.74B | $1.68B | 45.09% |
2021-03-31 | $3.32B | $1.51B | 45.47% |
2020-12-31 | $2.66B | $1.07B | 40.33% |
2020-09-30 | $3.23B | $0.86B | 26.60% |
2020-06-30 | $2.98B | $0.69B | 23.15% |
2020-03-31 | $2.89B | $0.60B | 20.92% |
2019-12-31 | $2.88B | $0.60B | 20.87% |
2019-09-30 | $2.84B | $0.56B | 19.82% |
2019-06-30 | $2.80B | $0.55B | 19.52% |
2019-03-31 | $2.78B | $0.54B | 19.34% |
2018-12-31 | $2.78B | $0.53B | 18.98% |
2018-09-30 | $2.66B | $0.49B | 18.33% |
2018-06-30 | $2.54B | $0.47B | 18.36% |
2018-03-31 | $2.39B | $0.43B | 17.89% |
2017-12-31 | $2.26B | $0.41B | 18.17% |
2017-09-30 | $2.18B | $0.40B | 18.42% |
2017-06-30 | $2.14B | $0.40B | 18.58% |
2017-03-31 | $2.13B | $0.39B | 18.21% |
2016-12-31 | $2.12B | $0.40B | 18.77% |
2016-09-30 | $2.00B | $0.35B | 17.56% |
2016-06-30 | $2.05B | $0.35B | 17.29% |
2016-03-31 | $2.08B | $0.36B | 17.34% |
2015-12-31 | $2.11B | $0.37B | 17.34% |
2015-09-30 | $2.10B | $0.30B | 14.51% |
2015-06-30 | $2.07B | $0.29B | 13.89% |
2015-03-31 | $2.07B | $0.29B | 13.99% |
2014-12-31 | $2.07B | $0.28B | 13.48% |
2014-09-30 | $2.22B | $0.40B | 17.90% |
2014-06-30 | $2.20B | $0.40B | 18.24% |
2014-03-31 | $2.18B | $0.38B | 17.18% |
2013-12-31 | $2.16B | $0.36B | 16.74% |
2013-09-30 | $2.13B | $0.24B | 11.12% |
2013-06-30 | $2.12B | $0.22B | 10.38% |
2013-03-31 | $2.10B | $0.23B | 10.95% |
2012-12-31 | $2.11B | $0.24B | 11.25% |
2012-09-30 | $2.08B | $0.25B | 11.82% |
2012-06-30 | $2.03B | $0.24B | 11.65% |
2012-03-31 | $1.98B | $0.22B | 11.10% |
2011-12-31 | $1.92B | $0.21B | 11.05% |
2011-09-30 | $1.85B | $0.27B | 14.84% |
2011-06-30 | $1.81B | $0.27B | 15.12% |
2011-03-31 | $1.76B | $0.26B | 15.04% |
2010-12-31 | $1.70B | $0.25B | 14.63% |
2010-09-30 | $1.54B | $0.23B | 14.85% |
2010-06-30 | $1.49B | $0.20B | 13.33% |
2010-03-31 | $1.51B | $0.20B | 13.45% |
2009-12-31 | $1.55B | $0.20B | 12.90% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.539B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $124.869B | 15.67 |
Cencora (COR) | United States | $48.051B | 19.18 |
ICON (ICLR) | Ireland | $25.434B | 24.01 |
DiDi Global (DIDIY) | China | $24.387B | 0.00 |
Avantor (AVTR) | United States | $16.238B | 23.94 |
Viatris (VTRS) | United States | $13.880B | 3.96 |
CochLear (CHEOY) | $13.776B | 0.00 | |
Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
Charles River Laboratories (CRL) | United States | $11.798B | 21.51 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
Natera (NTRA) | United States | $11.205B | 0.00 |
Solventum (SOLV) | United States | $11.115B | 0.00 |
HealthEquity (HQY) | United States | $6.886B | 51.45 |
Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
Organon (OGN) | United States | $4.742B | 4.59 |
Doximity (DOCS) | United States | $4.444B | 33.08 |
PACS (PACS) | United States | $3.713B | 0.00 |
Sotera Health (SHC) | United States | $3.227B | 15.83 |
Surgery Partners (SGRY) | United States | $3.108B | 28.88 |
Progyny (PGNY) | United States | $3.079B | 51.68 |
GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
Life Times (LTH) | United States | $2.783B | 30.76 |
Premier (PINC) | United States | $2.511B | 9.19 |
Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
Agilon Health (AGL) | United States | $2.055B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
Agiliti (AGTI) | United States | $1.368B | 22.33 |
NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
Embecta (EMBC) | United States | $0.594B | 3.92 |
InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
Enhabit (EHAB) | United States | $0.503B | 45.59 |
COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
LifeMD (LFMD) | United States | $0.482B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
Beauty Health (SKIN) | United States | $0.400B | 0.00 |
CareDx (CDNA) | United States | $0.391B | 0.00 |
DocGo (DCGO) | United States | $0.376B | 60.17 |
MultiPlan (MPLN) | United States | $0.371B | 0.00 |
Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
ModivCare (MODV) | United States | $0.335B | 4.44 |
Sharecare (SHCR) | United States | $0.290B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
Biodesix (BDSX) | United States | $0.142B | 0.00 |
So-Young (SY) | China | $0.125B | 41.83 |
Oncology Institute (TOI) | United States | $0.085B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
NeueHealth (NEUE) | United States | $0.050B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
Nutex Health (NUTX) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |